We are live on ! Find out more
SIM

Sentry Investment Management Portfolio holdings

AUM $146M
1-Year Est. Return 23.67%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+23.67%
3 Year Est. Return
+94.52%
5 Year Est. Return
+132.31%
10 Year Est. Return
+450.55%
AUM
$1.85B
AUM Growth
+$161M
Cap. Flow
+$20.7M
Cap. Flow %
1.12%
Top 10 Hldgs %
44.31%
Holding
545
New
19
Increased
207
Reduced
207
Closed
22

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.53M
2
OLN icon
Olin
OLN
+$4.38M
3
MRK icon
Merck
MRK
+$4.09M
4
B
Barrick Mining
B
+$3.9M
5
GE icon
GE Aerospace
GE
+$3.31M

Sector Composition

Rank Sector Weight
1 Financials 9.09%
2 Healthcare 8.16%
3 Technology 7.64%
4 Industrials 6.46%
5 Energy 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
51
iShares Core US Aggregate Bond ETF
AGG
$137B
$5.75M 0.31%
53,978
+19,961
+59% +$2.14M
TFCFA
52
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$5.7M 0.31%
161,932
+50,638
+45% +$1.71M
RTX icon
53
RTX Corp
RTX
$301B
$5.66M 0.31%
78,994
-15,890
-17% -$1.08M
MCD icon
54
McDonald's
MCD
$196B
$5.56M 0.3%
57,334
+11,300
+25% +$1.09M
EBAY icon
55
eBay
EBAY
$48.9B
$5.46M 0.29%
236,557
+64,145
+37% +$1.42M
BA icon
56
Boeing
BA
$184B
$5.44M 0.29%
39,889
-6,199
-13% -$806K
META icon
57
Meta Platforms (Facebook)
META
$1.5T
$5.38M 0.29%
+98,400
New +$4.94M
WBA
58
DELISTED
Walgreens Boots Alliance
WBA
$5.18M 0.28%
90,265
+20,400
+29% +$1.19M
BMY icon
59
Bristol-Myers Squibb
BMY
$131B
$5.12M 0.28%
96,278
-35,890
-27% -$1.83M
TMO icon
60
Thermo Fisher Scientific
TMO
$214B
$5.11M 0.28%
45,900
-23,900
-34% -$2.38M
MMM icon
61
3M
MMM
$93.2B
$5.1M 0.28%
43,493
-10,493
-19% -$1.12M
AMGN icon
62
Amgen
AMGN
$219B
$4.97M 0.27%
43,543
-2,300
-5% -$262K
COP icon
63
ConocoPhillips
COP
$140B
$4.95M 0.27%
70,050
-14,400
-17% -$1.03M
MCK icon
64
McKesson
MCK
$102B
$4.92M 0.27%
30,500
-2,200
-7% -$338K
ABBV icon
65
AbbVie
ABBV
$431B
$4.82M 0.26%
91,320
-17,880
-16% -$879K
AON icon
66
Aon
AON
$76.5B
$4.5M 0.24%
53,700
+16,400
+44% +$1.3M
FCX icon
67
Freeport-McMoran
FCX
$95.5B
$4.46M 0.24%
118,288
+54,800
+86% +$1.94M
UNH icon
68
UnitedHealth
UNH
$367B
$4.39M 0.24%
58,366
-6,900
-11% -$496K
UNP icon
69
Union Pacific
UNP
$175B
$4.39M 0.24%
52,216
-16,802
-24% -$1.33M
DD
70
DELISTED
Du Pont De Nemours E I
DD
$4.32M 0.23%
70,002
+21,352
+44% +$1.23M
UPS icon
71
United Parcel Service
UPS
$87.8B
$4.28M 0.23%
40,702
-8,385
-17% -$826K
GS icon
72
Goldman Sachs
GS
$301B
$4.26M 0.23%
24,018
-9,400
-28% -$1.55M
HON icon
73
Honeywell
HON
$76.3B
$4.14M 0.22%
50,380
-11,351
-18% -$887K
CELG
74
DELISTED
Celgene Corp
CELG
$3.99M 0.22%
47,200
+20,000
+74% +$1.58M
PNC icon
75
PNC Financial Services
PNC
$101B
$3.93M 0.21%
50,700
-11,700
-19% -$877K

Similar funds

Sentry Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Sentry Investment Management held 545 positions worth $1.85B, up 9.5% from $1.69B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sentry Investment Management's Q4 2013 filing shows 19 new, 207 increased, 207 reduced and 22 closed positions. Its largest new stake was Meta Platforms (Facebook): 98,400 shares worth $5.38M. The largest sale was Pfizer, an estimated $4.53M.

By sector, the portfolio is most concentrated in Financials at 9.1% of assets, up from 8.8% a quarter earlier, followed by Healthcare and Technology.

  • Sentry Investment Management's largest Q4 2013 buy was Meta Platforms (Facebook): 98,400 shares worth $5.38M.
  • Sentry Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2013, an estimated $8.76M increase.
  • Sentry Investment Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $4.53M.
  • Sentry Investment Management fully exited Olin in Q4 2013, selling an estimated $4.38M.
  • Sentry Investment Management's ten largest holdings make up 44% of its $1.85B portfolio in Q4 2013.
  • Sentry Investment Management opened 19 new positions and closed 22 in Q4 2013.
  • Sentry Investment Management's portfolio value rose 9.5% quarter-over-quarter to $1.85B.

Based on Sentry Investment Management's 13F filing for Q4 2013, filed 10 Feb 2014.